Not sure if you're a candidate for hair transplant surgery? This guide walks through the evaluation criteria surgeons use, who qualifies, and what alternatives exist for different hair loss profiles.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
Candidacy depends on multiple factors — hair loss stage, donor supply, scalp health, and medical history are all evaluated together.
Procedures like FUE, FUT, DHI, and Sapphire FUE each suit different candidate profiles; the right choice depends on your specific situation.
Certain conditions (active alopecia areata, uncontrolled diabetes, bleeding disorders) may make surgery unsafe or require specialist clearance first.
AGA is progressive — transplant restores existing hair but does not stop future loss; ongoing management is typically needed.
For medical tourists, continuity-of-care planning (local follow-up at home) is a critical part of candidacy assessment.
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Understanding Hair Transplant Candidacy
Candidacy for hair transplant surgery is not determined by a single factor. Surgeons evaluate a combination of hair loss type and stage, donor supply quality, scalp health, general medical status, and the stability of your loss pattern before making a recommendation. There is no universal "ideal candidate" profile — each case is assessed holistically.
The primary condition addressed by hair transplant surgery is androgenetic alopecia (AGA), commonly called male or female pattern baldness. AGA is progressive and inherited — it continues over time even after a transplant, according to the ISHRS androgenetic alopecia overview. Other hair loss types such as alopecia areata, telogen effluvium, or traction alopecia may not be reliably addressed by transplant, since the underlying cause differs.
A candidate typically has:
Moderate hair loss (Norwood II–V for men; Ludwig I–II for women)
Adequate donor supply in the safe zone (back and sides of the scalp)
Realistic expectations about achievable density and coverage
No active conditions in the donor or recipient areas
Who Is Not Yet a Candidate
Conditions that may temporarily defer or disqualify surgery
Active alopecia areata — surgery may trigger a flare or accelerate loss
Very early-stage loss where the pattern is not yet established — misaligned graft placement becomes a risk
Insufficient donor supply relative to the area needing coverage
Unrealistic expectations about density — a consultation should address this before any decision
Medical contraindications including uncontrolled diabetes, bleeding disorders, active scalp infection, or severe cardiovascular disease — these may require specialist clearance before surgery is considered safe
According to the NHS hair loss guidance, patients are advised to see a general practitioner before approaching a commercial hair clinic, particularly when underlying health conditions may be contributing to hair loss.
Candidacy Changes Over Time
AGA is progressive, and what is clinically appropriate at 30 may require a different approach at 50. Young patients under 25 with early-stage male pattern baldness are often treated conservatively — with medication such as finasteride — until the loss pattern stabilizes and a longer-term surgical plan can be made reliably, per the ISHRS followup procedures overview.
For women, hormonal shifts during pregnancy, breastfeeding, or menopause can change the stability of loss. Some women become better surgical candidates post-menopause when hormonal drivers decrease. The ISHRS hair transplant for women page notes that women's candidacy is more condition-dependent than men's, making thorough evaluation especially important.
Key Evaluation Criteria Clinicians Use
Surgeons use standardized tools and clinical assessments to determine whether you are a candidate and which technique is most appropriate.
Norwood Scale (Men) / Ludwig Scale (Women)
The Norwood scale classifies male pattern baldness into stages I–VII, with surgery typically considered for stages II–V. At higher Norwood stages (VI–VII), donor supply may be insufficient for full coverage, though targeted procedures can still provide meaningful improvement. The Mayo Clinic hair loss overview notes that no treatment is universally effective, making realistic expectation-setting essential.
For women, the Ludwig scale classifies diffuse thinning patterns. Because women's loss tends to be spread across the top of the scalp rather than in distinct Norwood patterns, candidacy depends heavily on maintaining sufficient donor zone density.
Donor Area Assessment
The donor area — typically the back and sides of the scalp — is evaluated for:
Follicle density (follicles per square centimeter)
Hair caliber (thickness affects visual density; finer hair may require more grafts)
Scalp laxity (for FUT strip harvest — looser scalps allow easier strip removal and closure)
Absence of thinning or alopecia in the donor zone
A limited donor supply is one of the most common reasons a patient may not be a candidate, or may need staged procedures rather than a single large session.
Scalp Health and Skin Condition
Active dermatitis, psoriasis, or infection in donor or recipient zones must be resolved before surgery. A history of keloid scarring raises the risk of raised or widened scars post-procedure. Prior surgeries or trauma in the harvest area may also affect outcomes and technique selection, per the ISHRS surgical standards.
Medical History Screening
Full disclosure protects your safety
Bleeding disorders or anticoagulant use can increase intraoperative bleeding risk. Autoimmune conditions such as lupus or active alopecia areata may result in poor graft take or trigger a flare post-surgery. Cardiac conditions often require medical clearance. Finasteride and minoxidil are generally safe to continue through surgery — but always disclose your full medication and health history to your surgical team.
Current medications are reviewed; some may need to be paused temporarily (such as blood thinners), while others are safe to continue. The ISHRS position statements outline surgeon obligations to conduct appropriate medical screening before any procedure.
Condition-Specific Candidacy Factors
Male Pattern Baldness (Androgenetic Alopecia)
Male pattern baldness is the most common transplant candidate profile. Best outcomes typically occur at Norwood III–V with robust donor supply, according to the ISHRS AGA overview. Early-onset MPB (under 25) is often deferred until the pattern stabilizes — operating on a moving target can result in graft placement that does not align with the final hairline as loss continues.
Results are best supported by ongoing medication (finasteride) to slow further loss in non-transplanted areas. The ISHRS medications page covers how finasteride works as a DHT blocker and its ongoing use requirements.
Women typically experience more diffuse loss than men, which affects candidacy. Donor zone density must be sufficient, and hormonal stability is important. High androgen levels (as in polycystic ovary syndrome) may require endocrine workup before surgery, per the ISHRS women's hair transplant page. Women who are pregnant, breastfeeding, or recently postpartum are typically not candidates until hormonal levels stabilize.
Hair transplant for women is viable but patient selection is more critical. See the female pattern hair loss option map for a full breakdown.
Afro-Textured Hair
Curly hair provides visual density at lower graft counts because curls create cross-sectional coverage. However, harvest technique may differ — FUE is often preferred to minimize linear scarring, per the ISHRS FUE overview. Higher risk of keloid scarring in some patients requires careful assessment.
Surgeon expertise matters significantly for this hair type. General surgeons may not have specific training on Afro-textured hair transplant candidacy and technique differences. See the Afro-textured hair transplant candidacy page for a complete guide.
Beard and Eyebrow Transplant
Beard transplants use scalp hair as the donor source. The texture may not perfectly match native beard hair — coarser or straighter growth can occur. Candidacy depends on the extent of desired coverage and available donor supply.
Eyebrow transplants use fine single-hair grafts and are only appropriate for patients with sufficient loss to warrant reconstruction. The ISHRS eyebrow transplant overview notes that candidacy depends on the nature and extent of loss.
Older hair transplants — particularly those using outdated plug techniques — can be revised. Candidacy depends on the availability of surrounding donor hair and the vascular health of the recipient area, per the ISHRS revision guidance. Multiple prior surgeries may deplete donor supply, limiting revision options.
Patients with unrealistic expectations may be declined even when a technical revision is possible. A surgeon prioritizing patient welfare over revenue will be transparent about what outcomes are realistically achievable. See the transplant revision or correction treatment page for more.
Surgical Options and Candidacy Fit
The four main surgical techniques each suit different candidate profiles. Understanding these differences helps you know what questions to ask your surgeon.
Feature
FUE
FUT Strip
DHI
Sapphire FUE
Best for
Patients wanting no linear scar; smaller sessions
High graft counts in one session; limited donor flexibility
Dense packing; precise angle control
Patients seeking potentially reduced trauma vs. standard steel
Recovery time
Typically faster; small dot scars
Slightly longer; linear scar requires care
Comparable to FUE
May be slightly faster healing
Scar type
Tiny dot scars (no linear scar)
Single linear scar
Tiny dot scars (no linear scar)
Tiny dot scars (no linear scar)
Session size
Moderate per session; multiple sessions may be needed for larger areas
FUE involves individual follicle extraction using a punch tool. It leaves no linear scar, making it popular for patients who prefer to wear their hair short. However, candidates need adequate follicle density in the donor zone — very low density may mean FUE is not efficient. Some providers offer no-shave FUE for additional cost, though this is not universally available.
FUT (Follicular Unit Transplantation via Strip)
FUT removes a strip of tissue from the donor area and dissects it into follicular units under a microscope. It can yield higher graft numbers in a single session, making it suitable for patients needing extensive coverage. However, it requires sufficient scalp laxity for closure, and leaves a linear scar that may widen with tension.
DHI (Direct Hair Implantation)
DHI uses a Choi implanter pen to place follicles directly without pre-made recipient incisions. It allows dense packing and precise angle control but requires a highly experienced surgical team. Candidacy requires adequate donor supply and realistic density expectations.
Sapphire FUE
Sapphire FUE uses a sapphire-tipped instrument to create recipient sites. Claims of reduced trauma and faster healing are primarily surgeon-reported; evidence is limited. Candidacy is the same as standard FUE.
Non-Surgical Alternatives — Who They Suit
Surgery is not the only path, and for some patients, non-surgical options may be more appropriate — particularly when loss is early-stage or surgery is contraindicated.
Finasteride (Oral DHT Blocker)
Finasteride works by blocking the hormone (DHT) that shrinks hair follicles in androgenetic alopecia. It is best for early-stage MPB and may slow progression or improve density in some users. It requires ongoing use — stopping reverses any benefits gained, per the ISHRS medications overview.
Finasteride is not suitable for women of childbearing potential due to risk of birth defects in male fetuses. Sexual side effects are rare but documented and should be discussed with your clinician.
Minoxidil (Topical/Oral)
Minoxidil is a vasodilator that extends the growth phase of the hair cycle. It may improve density in many users and tends to work best on smaller areas of thinning. Side effects include scalp irritation and initial shedding. Oral minoxidil is gaining popularity for women but typically requires cardiac monitoring.
Low-Level Light Therapy (LLLT)
LLLT (red light caps or helmets) has modest evidence for slowing hair loss. It is compliance-dependent — daily use is required for results. It may be used alongside medication or post-transplant to support graft health. Evidence is described as modest in the ISHRS LLLT overview.
Platelet-Rich Plasma (PRP)
PRP involves injecting a patient's concentrated platelets into the scalp. Evidence is mixed — some patients see meaningful improvement, others see minimal change. It requires multiple sessions and results are not permanent. The ISHRS PRP page covers the current evidence landscape.
Medications are ongoing, not one-time fixes
Finasteride, minoxidil, LLLT, and PRP all require continued use or maintenance to sustain results. If you are looking for a single procedure with no ongoing commitment, surgery may be more appropriate — but only if your candidacy supports it. These options are tools to be considered as part of a broader management plan, not alternatives to a decision about surgery.
Risk Controls and Safety Standards
Pre-Operative Requirements
Before surgery, a reputable clinic will require:
Blood work and medical clearance for patients with health conditions
Scalp examination to rule out active infection or inflammatory conditions
A realistic outcome consultation where the surgeon shows simulated results or reference photos from patients with similar profiles
The ISHRS position statements outline that surgeons should provide thorough pre-operative assessment and ensure patients understand realistic outcomes.
Red Flags That Should Give Patients Pause
Intraoperative Safety
Accredited surgical facilities reduce risk. General anesthesia carries a higher risk profile than local anesthesia with sedation — understand which your clinic uses and why. In teaching facilities, clarify who performs which steps — graft extraction is typically done by clinical staff, not the supervising surgeon, per the ISHRS guidelines.
Post-Operative Care and Complications
Common temporary side effects include swelling, numbness, crusting, and shock loss (temporary shedding of existing hair near the transplant site). Shock loss can occur and usually resolves, though it can be alarming to patients who were not warned it might happen.
Warning signs requiring immediate medical attention:
Fever above 38.5°C (101.5°F)
Excessive bleeding that does not stop with applied pressure
Signs of infection (increasing redness, warmth, pus, spreading swelling)
Severe pain not controlled by prescribed medication
Follow-up schedules typically include day 1, day 7, 3 months, 6 months, and 12 months post-procedure. For medical tourists, establishing a local follow-up physician at home before traveling is essential — graft monitoring cannot be done virtually.
For cost context on multiple procedures and revisions, see our cost considerations page.
Candidacy Checklist — Questions to Ask Your Surgeon
Before committing to a procedure, ask these questions during your initial consultation. A surgeon who can answer all of these clearly is demonstrating the transparency and accountability standards you should expect.
Before your consultation
Consider completing the self-assessment checklist first. Knowing where you stand on Norwood stage, donor supply, and medical history will help you evaluate whether the surgeon's answers are consistent with what you observe.
Questions for your initial consultation:
What Norwood (men) or Ludwig (women) stage do I fall in, and what outcome is realistic for my donor supply?
What technique do you recommend and why — FUE, FUT, or DHI?
What is your ABHRS certification or equivalent credentials?
Do you have before-and-after photos of patients with similar loss patterns and hair type?
What is your complication rate, and how are post-op emergencies handled?
Will a medical clearance be required based on my health history?
If I am traveling for surgery, what follow-up support do you provide once I return home?
What happens if my grafts do not take as expected — is a revision included in my plan?
Will I need additional procedures (medication, PRP) to maintain my results?
Can I speak with former patients about their experience?
If you have reviewed the candidacy criteria and believe you may be a candidate, our coordination team can help you schedule a virtual consultation or connect you with verified surgeons.